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The complex repair of thoracoabdominal and
descending thoracic aortic aneurysms requires inter-
ruption of blood flow in the arterial system’s central
conduit. Interruption of circulation may cause pro-
longed ischemia and associated end-organ damage.
As surgical technique has evolved, several adjuncts
have been described that minimize ischemic time
and aid in organ preservation. We have previously
examined the factors implicated in postoperative
injury of the heart, spinal cord, kidneys, and lungs
and have explored possible methods to avoid such
complications. In this article we focus on the reduc-
tion of insult to the liver during thoracoabdominal
and descending thoracic aortic aneurysm repair.
Ischemia is a well-documented source of hepat-
ic injury, and ischemic hepatitis is known to cause
elevation of enzyme levels.1-4 No single test or pro-
cedure can measure the total function of the liver
because it is involved in nearly every metabolic
process in the body. In this study we did not
attempt to diagnose liver disease but instead used a
variety of laboratory and statistical tests to identify
hepatic insult and also to identify risk factors for
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ORIGINAL ARTICLES
such insult that may be amenable to modification
through refinements in surgical technique. We report
a comparison of baseline to postoperative enzyme
measurements used to determine the impact of vis-
ceral and distal perfusion on liver function after tho-
racoabdominal and descending thoracic aortic repair.
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Table I. Patient characteristics
Variable No. of patients (%) No. of abnormal test results (%) Odds ratio* 95% CI† p‡
All patients 286 (100.0) 35 (12.2)
Age $ 60 215 (75.2) 28 (13.0) 1.37 0.57 to 3.29 0.48
Age < 60 71 (24.8) 7 (9.9) 1
Female 106 (37.1) 15 (14.2) 1.31 0.64 to 2.70 0.45
Male 180 (63.9) 20 (11.1) 1
Hypertensive 220 (76.9) 31 (14.1) 2.54 0.87 to 7.49 0.08
Otherwise 66 (23.1) 4 (6.1) 1
Smoker 110 (38.5) 16 (14.6) 1.41 0.69 to 2.87 0.35
Nonsmoker 176 (61.5) 19 (10.8) 1
Renal insufficiency 55 (19.2) 6 (10.9) 0.86 0.34 to 2.17 0.74
Otherwise 231 (80.8) 29 (12.6) 1
COPD 85 (29.7) 12 (14.1) 1.27 0.61 to 2.69 0.53
Otherwise 201 (70.3) 23 (11.4) 1
Cerebrovascular disease 34 (11.9) 5 (14.7) 1.28 0.46 to 3.54 0.64
Otherwise 252 (88.1) 30 (11.9) 1
Diabetes 26 (9.1) 3 (11.5) 0.93 0.26 to 3.27 0.91
Otherwise 260 (90.9) 32 (12.3) 1
History of hepatitis 8 (2.8) 3 (37.5) 4.61 1.05 to 20.22 0.03
Otherwise 278 (97.2) 32 (11.5) 1
TAAA I 90 (31.5) 5 (5.6) 0.33 0.12 to 0.87 0.02
Otherwise 196 (68.5) 30 (15.3) 1
TAAA II 100 (34.9) 21 (21.0) 3.27 1.58 to 6.76 0.001
Otherwise 186 (65.1) 14 (7.5) 1
TAAA III 33 (11.5) 4 (12.1) 0.99 0.33 to 3.00 0.98
Otherwise 253 (88.5) 31 (12.3) 1
TAAA IV 27 (9.4) 3 (11.1) 0.89 0.25 to 3.11 0.85
Otherwise 259 (90.6) 32 (12.4) 1
Acute dissection 13 (4.6) 1 (7.7) 0.59 0.07 to 4.65 0.61
Otherwise 273 (95.4) 34 (12.5) 1
Rupture 17 (5.9) 6 (35.3) 4.51 1.55 to 13.12 0.003
Otherwise 269 (94.1) 29 (10.8) 1
Emergency 23 (8.0) 8 (34.8) 4.66 1.81 to 12.00 0.001
Otherwise 263 (92.0) 27 (10.3) 1
Adjunct 174 (60.9) 21 (12.1) 0.96 0.47 to 1.98 0.91
Otherwise 112 (39.2) 14 (12.5) 1
Distal perfusion§ 116 (62.4) 8 (6.9) 0.79 0.26 to 2.38 0.68
Otherwise 70 (37.6) 6 (8.6) 1
Visceral perfusion¶ 80 (80.0) 15 (18.8) 0.54 0.18 to 1.63 0.27
Otherwise 20 (20.0) 6 (30.0) 1
Abnormal laboratory values were considered to be present if any one of AST, ALT, LDH, alkaline phosphatase, PT, or PTT were
greater than 4 times top normal for our laboratory, or total bilirubin was greater than 10. Adjunct use (distal aortic perfusion + cere-
brospinal fluid drainage) is shown for all aneurysm types. Distal aortic perfusion alone is shown for non–type II aneurysms. Visceral per-
fusion, which can be performed only when visceral vessel aortic insertions are exposed, is shown only for patients with type II aneurysms.
CI, Confidence interval; COPD, chronic obstructive pulmonary disease; TAAA I to IV, thoracoabdominal aortic aneurysm Crawford
class I, II, III, or IV.
*Odds ratio represents a test against a reference category whose referent odds ratio is equal to 1.
†95% CI reflects the units against which its companion odds ratio is computed. Confidence intervals are test-based.
‡p is the probability of a type I statistical error (common p value). Values are Pearson c2 probabilities.
§Type I, III, IV, and descending aneurysms only (n = 186).
¶Type II aneurysms only.
PATIENTS AND METHODS
Patients. Between January 1991 and July 1996,
we performed thoracoabdominal or descending tho-
racic aortic aneurysm repair in 367 patients. Baseline
and postoperative total bilirubin, alanine amino-
transferase (ALT or SGPT), aspartate aminotrans-
ferase (AST or SGOT), alkaline phosphatase, lactate
dehydrogenase (LDH), fibrinogen, prothrombin
time (PT), and partial thromboplastin time (PTT)
were measured for 286 patients. We examined the
impact of distal and visceral perfusion on liver func-
tion as compared with simple cross-clamp technique.
Postoperative values analyzed were the highest val-
ues recorded in the interval between awakening
from anesthesia and discharge from the hospital.
Table I describes the pertinent characteristics of the
study population.
Surgical technique. The majority of patients
(174; 61%) underwent thoracoabdominal and
descending thoracic aortic graft replacement with
cerebral spinal fluid drainage, distal aortic perfusion,
and moderate hypothermia, with reattachment of
intercostal arteries, which we have described at
length previously.5 For pump cases, all patient types
received distal aortic perfusion. For the most exten-
sive aneurysms—thoracoabdominal type II—direct
perfusion of the visceral arteries was begun as illus-
trated in Fig. 1 when the distal aneurysm was
opened. Although repair of some other aneurysm
types (III and IV) involves exposure of the visceral
arteries, we do not perfuse these arteries directly
because of the relatively short time required to per-
form such repairs. Sixty-seven (23%) patients under-
went graft replacement without adjuncts using the
simple cross-clamp technique.
Cross-clamping and graft replacement was per-
formed in segmental and sequential fashion. For
pump cases, after induction of anesthesia a 14-gauge
Tuohy needle was inserted in the intervertebral
space between L3 and L4 for cerebral spinal fluid
drainage, and the chest was opened through a left
thoracoabdominal incision through the sixth inter-
costal space. The sixth rib was removed. A catheter
for distal aortic perfusion was placed in the left com-
mon femoral artery after a left groin incision, and
the left atrial appendage was cannulated for the
venous portion of cardiofemoral bypass after the
pericardium was opened, posterior to the left
phrenic nerve. The initial placement of clamps was
just distal to the left subclavian artery and at the
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Fig. 1. Visceral perfusion of celiac axis, superior mesen-
teric artery, and renal arteries.
Fig. 2. Depiction of linear regression equation shown in
Table IV for AST. Solid line represents relationship
between preoperative and postoperative variables for type
I, III, IV, and descending thoracic aneurysms. Line with
short dashes represents this relationship for type II
aneurysms without visceral perfusion. Long-dashed line
represents relationship in type II patients who received vis-
ceral perfusion during operation. Type II aneurysm extent
is associated with upward shift in postoperative variable
values, whereas use of visceral perfusion brings relation-
ship back to essentially that of other aneurysm types.
mid-descending aorta. After proximal anastomosis
of the graft to the descending thoracic aorta, the dis-
tal clamp was moved to the infrarenal abdominal
aorta. The remainder of the aneurysm was then
opened. Visceral perfusion of the celiac axis, superi-
or mesenteric artery, and right and left renal arteries
for thoracoabdominal aortic aneurysm type II was
via #9 Pruitt catheter. The rate of flow to the viscer-
al arteries depended on proximal aortic pressure and
ranged from 200 to 600 ml/min. Finally, after reat-
tachment of the intercostal and visceral arteries, the
distal anastomosis was performed.
Statistical methods. For the categorical analyses
that pertain to Tables I and II, an indicator variable
for abnormal results was set to 1 if any of the labo-
ratory values of alkaline phosphatase, LDH, AST,
ALT, PT, or PTT was greater than four times the
upper limit of the normal range, or if total bilirubin
was greater than 10. For the analyses pertinent to
Table III, two criteria for abnormal laboratory
results were compared. One considered anything
above four times the upper limit of the normal range
to be abnormal as described above (4´ top normal),
and the other considered two times the upper limit
of the normal range to be abnormal (2´ top nor-
mal). Univariate frequency analysis was conducted
using contingency table tests, and multivariate fre-
quency analysis was performed using multiple logis-
tic regression.
Linear regression models were used to evaluate
the effects of aneurysm extent and distal and viscer-
al perfusion on postoperative laboratory values
expressed as continuous variables. All computations
were performed using SAS software version 6.12.
Visceral perfusion was only used in type II tho-
racoabdominal aortic aneurysm repairs as described
above. In contingency table analysis, evaluation of
visceral perfusion was confined to type II cases,
where it was actually applied. In the linear regression
analyses, an indicator variable for visceral perfusion
was applied to the entire population.
RESULTS
The univariate relationships between patient
characteristics and one or more abnormal liver func-
tion–related laboratory values are shown in Table I.
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Table II. Multiple logistic regression model
Variable Parameter estimate Standard error Adjusted odds ratio 95% CI p
Intercept – 3.0202 0.297 0.0001
TAAA II 1.2044 0.374 3.34 1.60 to 6.94 0.0013
History of hepatitis 1.7060 0.815 5.51 1.12 to 27.19 0.0363
Emergency case 1.1724 0.478 3.23 1.26 to 8.25 0.0143
CI, Confidence interval; TAAA II, thoracoabdominal aortic aneurysm.
Table III. Effect of abnormal laboratory value threshold on associations between risk factors and outcomes
Variable No. 2´ top                    Odds 4´ top Odds
normal criterion ratio              p normal criterion ratio p
All patients 286 74 (25.9) 35 (12.2)
History of hepatitis 8 4 (50.0) 2.97 0.11 3 (37.5) 4.61 0.03
Otherwise 278 70 (25.2) 1 32 (11.5) 1
Renal insufficiency 55 21 (38.2) 2.07 0.02 6 (10.9) 0.86 0.74
Otherwise 231 53 (22.9) 1 29 (12.6) 1
Diabetes 26 11 (42.3) 2.29 0.045 3 (11.5) 0.93 0.91
Otherwise 260 63 (24.2) 1 32 (12.3) 1
TAAA II 100 40 (40.0) 2.98 0.001 21 (21.0) 3.27 0.001
Otherwise 186 34 (18.3) 1 14 (7.5) 1
Rupture 17 8 (47.1) 2.73 0.04 6 (35.3) 4.51 0.003
Otherwise 269 66 (24.5) 1 29 (10.8) 1
Emergency 23 14 (60.9) 5.26 0.001 8 (34.8) 4.66 0.001
Otherwise 263 60 (22.8) 1 27 (10.3) 1
Visceral perfusion* 80 31 (38.8) 0.77 0.61 15 (18.8) 0.54 0.27
Otherwise 20 9 (45.0) 1 6 (30.0) 1
TAAA II, Thoracoabdominal aortic aneurysm type II.
*Type II aneurysms only.
Abnormal liver function, presented in Table I, is
defined by the 4´ top normal criterion described in
the Methods section above. Overall, 35 patients had
laboratory abnormalities by this criterion. Significant
univariate predictors were history of hepatitis, type
II aortic aneurysm, ruptured aortic aneurysm, and
emergency presentation.
Table II shows a multiple logistic regression
analysis that demonstrates the significant indepen-
dent effects of type II aneurysm, history of hepatitis,
and emergency presentation on the probability of
having abnormal postoperative liver-related labora-
tory results.
Table III shows the effect of abnormal laborato-
ry value threshold on univariate associations bet-
ween risk factors and abnormal laboratory results.
On the left hand side of the table, laboratory values
greater than 2´ top normal are considered abnor-
mal. On the right side, values greater than 4´ top
normal are considered abnormal. With the 2´ crite-
rion, renal insufficiency, diabetes, type II aneurysm,
rupture, emergency presentation, and intraoperative
perfusion of the visceral arteries are significantly
associated with laboratory abnormalities. With the
4´ criterion, history of hepatitis, type II aneurysm,
ruptured aneurysm, emergency presentation, and
use of visceral perfusion are significantly associated
with abnormal laboratory values. The last row of
Table III shows visceral perfusion confined only to
type II aneurysms—the type of aneurysm repair for
which it was used. Although not statistically signifi-
cant (probably because of small numbers of events),
visceral perfusion appears to mitigate the effects of
type II aneurysm. This conclusion is borne out by
statistically significant data shown in Table IV.
Table IV shows the results of multiple linear
regression analyses for individual postoperative lab-
oratory values. Laboratory tests that had at least
one significant predictor are included in the table.
In general, the strongest predictor for each postop-
erative laboratory value was the baseline value of
that same variable. For alkaline phosphatase, the
preoperative value, type II aneurysm, and visceral
perfusion were all highly significant predictors. For
JOURNAL OF VASCULAR SURGERY
Volume 27, Number 1 Safi et al. 149
Table IV. Determinants of postoperative laboratory values—multiple linear regression models
Variable Parameter estimate Partial R2 p
Postoperative alkaline phosphatase
Intercept 46.095 0.0001
Preoperative alkaline phosphatase 0.989 0.872 0.0001
TAAA II 114.374 0.177 0.0001
Visceral perfusion –101.181 0.127 0.0001
Postoperative AST
Intercept 148.600 0.27
Preoperative AST 1.983 0.19 0.0001
TAAA II 491.028 0.019 0.13
Visceral perfusion –500.136 0.018 0.15
Postoperative PT
Intercept –0.093 0.84
Preoperative PT 1.142 0.725 0.0001 
TAAA II 1.999 0.017 0.04
Visceral perfusion –1.810 0.012 0.07
Postoperative PTT
Intercept 1.151 0.84
Preoperative PTT 1.152 0.654 0.0001
TAAA II 6.742 0.021 0.03
Visceral perfusion –5.631 0.013 0.02
Postoperative AST (interaction model)
Intercept 151.40 0.23
Preoperative AST 1.94 0.0001
TAAA II –1436.64 0.03
Visceral perfusion 805.16 0.29
AST + TAAA II 68.22 0.001
AST + visceral perfusion –47.03 0.05
Multiple linear regression analysis of influence of baseline variable values, aneurysm type, and use of visceral perfusion on postopera-
tive variable values. Partial R2 is the proportion of variance in postoperative values accounted for by each explanatory variable. Partial R2
is calculated using type II sums of squares, which present each statistic as though it were included as the final term in the model.
Parameter estimates for preoperative variables represent the average change in postoperative value for each one-unit change in preoper-
ative value. Parameter estimates for TAAA II and visceral perfusion indicate the average change in postoperative variable value that is
associated with the presence of the predictors. Note that use of visceral perfusion reduces the average postoperative value by approxi-
mately the amount that the postoperative value is increased by type II aneurysm.
TAAA II, Thoracoabdominal aortic aneurysm type II
AST, only the baseline value was predictive. For
PT, baseline value and type II aneurysm were sig-
nificant, with visceral perfusion narrowly missing
statistical significance. For PTT, baseline value,
type II aneurysm, and visceral perfusion were all
significant predictors. For all laboratory tests, vis-
ceral perfusion decreased the postoperative value
by approximately the same amount as type II
aneurysm increased that value (Figs. 2 through 5).
DISCUSSION
Complex repair of the thoracoabdominal aorta
exposes patients to ischemic insult and puts them at
risk for end-organ damage. We found that gross cor-
relates of ischemia, such as rupture and emergency
presentation, were significant predictors of liver
function abnormalities for all patients. Thoraco-
abdominal aortic aneurysm type II, of all aneurysm
types, is the most complex to repair and carries the
longest total ischemic time. In this series, the preva-
lence of postoperative liver dysfunction was highest
in patients with type II aneurysms. In many previous
studies, this type of aneurysm has been shown to be
associated with neurologic, renal, and pulmonary
complications, as well as a diminished long-term sur-
vival rate.5-10
Liver dysfunction is difficult to study because the
diagnosis is made clinically, so that definitive criteria
for diagnosing liver disease from retrospective data
do not exist. Despite the difficulty of diagnosis,
however, practical measurements of clinical labora-
tory values can be used to study hepatic insult after
surgery. Bilirubin results from the metabolism of
heme in the tissues. The liver conjugates the pig-
ment and excretes it against an energy-dependent
gradient in the bile. Elevated serum bilirubin can
result from a wide variety of acquired and congeni-
tal disorders, and hepatic ischemia has been report-
ed to cause hyperbilirubinemia. Alkaline phos-
phatase is a widespread enzyme found in especially
high concentrations in the intestines, kidneys, bone,
liver, and placenta. In normal adults the liver is a
major source of the serum concentrations of this
enzyme. LDH, like alkaline phosphatase, is widely
distributed in the liver, red blood cells, and skeletal
and cardiac muscle. Biliary obstruction and intra-
hepatic cholestasis can cause elevations of this
enzyme. Hepatic parenchymal cell injury usually
causes only a twofold to threefold elevation of alka-
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Fig. 3. Depiction of linear regression equation shown in
Table IV for alkaline phosphatase. Solid line represents
relationship between preoperative and postoperative vari-
ables for type I, III, IV, and descending thoracic
aneurysms. Line with short dashes represents this relation-
ship for type II aneurysms without visceral perfusion.
Long-dashed line represents relationship in type II patients
who received visceral perfusion during operation. Type II
aneurysm extent is associated with upward shift in postop-
erative variable values, whereas use of visceral perfusion
brings relationship back to essentially that of other
aneurysm types.
Fig. 4. Depiction of linear regression equation shown in
Table IV for PT. Solid line represents relationship between
preoperative and postoperative variables for type I, III, IV,
and descending thoracic aneurysms. Line with short dash-
es represents this relationship for type II aneurysms with-
out visceral perfusion. Long-dashed line represents rela-
tionship in type II patients who received visceral perfusion
during operation. Type II aneurysm extent is associated
with upward shift in postoperative variable values, where-
as use of visceral perfusion brings relationship back to
essentially that of other aneurysm types.
line phosphatase. Alanine aminotransferase (ALT,
SGPT) and aspartate aminotransferase (AST,
SGOT) are sensitive indicators of hepatic parenchy-
mal cell injury. AST is present in both the cytoplasm
of liver parenchymal cells and in their mitochondria.
ALT is primarily a cytoplasmic enzyme and a more
sensitive marker of hepatocyte injury than AST.
Cardiac and skeletal muscle disorders can also cause
these enzymes to be released into the serum. The PT
is dependent on the production of adequate levels of
procoagulant proteins by the liver: factor VII, pro-
thrombin (II), X, V, and fibrinogen. Factor VII has
a half-life of only a few hours and requires a higher
rate of hepatic synthesis than the other procoagulant
proteins made by the liver. Hepatic parenchymal
cells probably also produce all the other procoagu-
lant proteins except for von Willebrand’s factor.
We approached the problem of measuring hepat-
ic insult in several ways. For the frequency analysis,
laboratory abnormalities were considered to exist if
any of the previously mentioned laboratory values
had a postoperative value greater than four times the
upper limit of normal. Values at four times top nor-
mal represent severe laboratory abnormalities. For
purposes of comparison, another criterion for abnor-
mality, two times top normal, was also studied. That
the two criteria lead to identification of different risk
factors in some cases is interesting. The less stringent
criterion (2´ top normal) tended to favor the less
liver-specific risk factors of renal failure and diabetes,
whereas the more stringent criterion (4´ top nor-
mal) identified the more liver-specific variable of his-
tory of hepatitis. We hypothesize that the more
severe abnormalities in laboratory values are more
specific to liver function, whereas the milder abnor-
malities are less specific in origin.
In addition to the categorical analyses, which
provided aggregate data about overall laboratory
abnormalities, we performed analyses on the indi-
vidual laboratory variables given as continuous data.
Information about the scale of a variable’s change is
available from continuous data in a way that it is not
from categorical data. To explore the way postoper-
ative enzyme levels scale with the risk factors, we
subjected the data to multiple linear regression
analysis. We used stepwise regression for the first
pass and then rebuilt the models by hand with vari-
ables identified in the stepwise selection. This was
done to minimize the influence of the tremendous
multicollinearity that existed between the laboratory
measures. For the variables AST, alkaline phos-
phatase, PT, and PTT, we found that each variable’s
baseline value was the strongest predictor, and that
type II aneurysm and the use of visceral perfusion
were the most important predictors of postoperative
value (Table IV).
We noted in the Methods section that visceral per-
fusion was evaluated only in type II aneurysms for the
contingency table analyses, whereas it was evaluated
across the entire population for the linear regression
analyses. The reason for the difference is the follow-
ing. In the contingency tables, the association of vis-
ceral perfusion with laboratory abnormalities would
be confounded with the effect of type II aneurysm,
which has a strong association with laboratory abnor-
malities, because visceral perfusion was not used in
any other aneurysm types. Therefore, it would be
impossible to evaluate the effect of visceral perfusion
if the denominator for the comparison contained
lower-risk aneurysm types for which it would never be
used. In the regression analyses, on the other hand,
because indicator variables are used to describe the
effects of visceral perfusion, aneurysms that do not
use this perfusion type do not contribute information.
When solving the equations using the linear regres-
sion formulas, the visceral perfusion coefficients
should only be subtracted from equations that also
contain the type II aneurysm term.
JOURNAL OF VASCULAR SURGERY
Volume 27, Number 1 Safi et al. 151
Fig. 5. Depiction of linear regression equation shown in
Table IV for PTT. Solid line represents relationship
between preoperative and postoperative variables for type
I, III, IV, and descending thoracic aneurysms. Line with
short dashes represents this relationship for type II
aneurysms without visceral perfusion. Long-dashed line
represents relationship in type II patients who received vis-
ceral perfusion during operation. Type II aneurysm extent
is associated with upward shift in postoperative variable
values, whereas use of visceral perfusion brings relation-
ship back to essentially that of other aneurysm types.
Our analysis of liver function–related laboratory
tests indicates that history of hepatitis, as a marker
for preexisting liver disease, and type II aneurysm
extent, acute rupture, and emergency presentation,
as markers of ischemia, are risk factors for hepatic
injury after thoracoabdominal aortic repair. Use of
visceral perfusion during type II aneurysm surgery
effectively negates the rise in postoperative laborato-
ry values associated with type II aneurysm repairs
performed with the simple cross-clamp technique.
Special thanks to our editor, Amy Wirtz Newland.
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DISCUSSION
Dr. James M. Seeger (Gainesville, Fla.). Thoraco-
abdominal aortic aneurysm repair is associated with signif-
icant morbidity and mortality rates, and the necessary vis-
ceral ischemia that is part of this procedure appears to be
an important risk factor for postoperative organ injury.
Pulmonary, renal, hematopoietic, and hepatic dysfunction
are common after thoracoabdominal aortic aneurysm
repair, usually occurring together, and multiorgan system
failure is the most common cause of death, at least in our
current series at the University of Florida. In addition, the
duration of visceral ischemia has been found to be a sig-
nificant predictor for organ dysfunction and death, and
the mechanism by which visceral ischemia includes both
local and distant organ injury after thoracoabdominal aor-
tic aneurysm repair, appears to be in part from activation
and release of proinflammatory cytokines upon reperfu-
sion of the ischemic viscera.
The study presented today has focused on hepatic
injury after thoracoabdominal aortic aneurysm repair and
demonstrated type II thoracoabdominal aortic aneurysm
repair, a history of hepatitis, emergency repair, and rup-
ture to be risk factors for significant liver enzyme elevation
after thoracoabdominal aortic aneurysm repair. In addi-
tion, visceral perfusion using left atrial femoral bypass dur-
ing type II thoracoabdominal aortic aneurysm repair was
shown to be somewhat protective for hepatic ischemia,
although to a lesser degree than one might expect. These
observations are similar to those of a recently presented
study of a smaller number of patients from our group, in
which left atrial femoral bypass was shown to decrease
hepatic as well as other organ injury after thoracoabdomi-
nal aortic aneurysm repair and to significantly limit the
systemic release of proinflammatory cytokines. These
observations lend increasing support to the hypothesis
that limiting the duration of visceral ischemia during tho-
racoabdominal aortic aneurysm repair, modulating the
local and systemic inflammatory response that is a conse-
quence of visceral ischemia/reperfusion, or both of these
will result in decreased morbidity rates and improved sur-
vival rates after thoracoabdominal aortic aneurysm repair.
I have four questions for the authors. First, what was
the average visceral ischemia time in patients who under-
went type II thoracoabdominal aortic aneurysm repair
with and without left atrial femoral bypass? Was there any
relationship that you observed between the duration of
visceral ischemia and hepatic or other organ injury?
Second, were any of the preoperative hepatic laboratory
values more or less specific in predicting liver dysfunction
after operation? We have had significant difficulty in deter-
mining who really has preoperative hepatic dysfunction
that is of importance. Third, was there a relationship
between hepatic injury and other organ dysfunction or
multiple organ dysfunction in your series? Finally, was left
atrial femoral bypass significantly protective in patients
who had preoperative hepatic dysfunction or cirrhosis to
allow thoracoabdominal aortic aneurysm repair to be per-
formed safely? We found hepatic dysfunction to be a par-
ticularly significant predictor of death after both thora-
coabdominal aortic aneurysm repair and infrarenal
abdominal aortic aneurysm repair, even so that we are now
quite wary of performing aortic surgery in patients who
have cirrhosis or severe hepatic dysfunction.
Dr. George V. Letsou. Thank you very much, Dr.
Seeger, for your comments. We also found that preopera-
tive liver dysfunction was a very significant predictor of
postoperative hepatic dysfunction. In a multivariate analy-
sis that we did not present here, the most important pre-
dictor of postoperative hepatic dysfunction is preoperative
hepatic dysfunction, especially the preoperative alkaline
phosphatase level, and in a multivariate analysis the preop-
erative liver status accounts for about 87% of the risk and
the type of aneurysm or extent of aneurysm accounts for
about 20% of the risk. If visceral perfusion is used, it can
decrease the risk by approximately 20%. The overwhelm-
ing predictor of postoperative dysfunction, as you point
out, is preoperative liver dysfunction. There was no more
relation between the visceral ischemic time and the inci-
dence of hepatic dysfunction in our series. I believe your
other question related to the relationship between hepatic
dysfunction and multisystem organ failure. We did not
analyze for multisystem organ failure in this series but just
for death, so it would be difficult to address the question
of multisystem organ failure in that fashion, although our
experience, I think, would be similar to yours in that most
of the patients who die do so of multisystem organ failure.
Dr. Richard P. Cambria (Boston, Mass.). Dr. Letsou,
congratulations on a nice presentation. In the December
1996 issue of the Journal of Vascular Surgery, we present-
ed similar data looking at a more in-depth profile of coag-
ulation factors and their relationship to hepatic and viscer-
al ischemia (1996;24:936-45). Most have correlated vis-
ceral ischemic problems with the threat of perioperative
coagulopathy. I may have missed it in your presentation,
but what was the relationship, if any, in your series
between visceral ischemia, liver function abnormalities,
and perioperative bleeding?
Dr. Letsou. We didn’t address perioperative bleeding in
this study, but when we assessed for liver function, we
looked at both preoperative and postoperative values for
PT, PTT, fibrinogen, alkaline phosphatase, AST, ALT, and
perhaps one or two others that I am missing. Of those fac-
tors, preoperative elevations in alkaline phosphatase were
the most important predictor of postoperative hepatic
problems. The PT, PTT, and fibrinogen also were statisti-
cally significant, whereas AST and ALT were not predic-
tors of postoperative hepatic dysfunction.
Dr. Bruce J. Gewertz (Chicago, Ill.). I also very much
enjoyed the paper and am aware of the terrific work you
do in this area. I am a little confused. If there was no cor-
relation between the time of intraoperative ischemia and
liver dysfunction, what is the mechanism for the liver dys-
function, and why would it necessarily be associated with
type II thoracoabdominal aortic aneurysms? Do you have
any thoughts about the mechanism?
Dr. Letsou. Well, I think that the objective is to mini-
mize ischemic time. I believe one of the reasons there was
no correlation in ischemic time is that the policy regarding
hepatic and visceral perfusion changed with time over the
course of the series from 1991 to 1996. Before 1992 most
patients were selectively perfused. After that time, it was
used as a pretty routine standard procedure in patients
who had type II extensive aneurysms. As a consequence,
the number of patients who had significant ischemic times
were mostly in the early part of the study and there are not
as many of them. I believe that is one reason that ischemic
time is not a significant factor. We do believe that mini-
mizing the ischemic time, which is the overall objective of
this technique, is an extremely important factor in mini-
mizing hepatic dysfunction and probably the explanation
for why there is less hepatic dysfunction.
Dr. W. Andrew Oldenburg (Jacksonville, Fla.). You
looked at aneurysm types, but did you also look at the
amount of visceral occlusive disease to begin with per
type?
Dr. Letsou. No, we did not look at the amount of vis-
ceral occlusive disease.
Dr. Oldenburg. Do you think that may have made a
difference?
Dr. Letsou. I think that most of the patients have a sig-
nificant amount of visceral occlusive disease; it is probably
present in about 60% to 80% of the patients. The number
of patients who do not have it, I think, would be small and
possibly would throw off the statistics, but I think that
probably is a very important factor.
Dr. Calvin B. Ernst (Ann Arbor, Mich.). It has been
suggested that patients with thoracoabdominal aneurysms
in whom postoperative multiorgan system failure develops
may have significant pancreatic ischemia with a resultant
release of proinflammatory cytokines from the ischemic
pancreas. Did you look at pancreatic ischemia and the var-
ious enzymes as such ischemia relates to the coagulopathy
after thoracoabdominal aortic aneurysm repair?
Dr. Letsou. We have a study to look at the pancreatic
function after operation, but we did not look at it for this
study, so I don’t think I can really comment on that.
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